Intermittent hypoxia conditioning prevents endothelial dysfunction and improves nitric oxide storage in spontaneously hypertensive rats

Experimental Biology and Medicine

Volumn 236, Issue 7, 2011, Pages 867-873

  Manukhina, Eugenia B ^a,b   Jasti, Dinesh ^a   Vanin, Anatoly F ^c   Fred Downey, H ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

Author keywords

Endothelium dependent relaxation; Hypertension; Nitric oxide; NO stores; Spontaneously hypertensive rats

Indexed keywords

ACETYLCHOLINE; ACETYLCYSTEINE; NITRIC OXIDE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; HYPOXIA; INTERMITTENT HYPOXIA CONDITIONING; MALE; NONHUMAN; RAT; STORAGE; VASCULAR RING;

ACETYLCHOLINE; ANIMALS; ANOXIA; AORTA; CONDITIONING (PSYCHOLOGY); ENDOTHELIAL CELLS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RATS; RATS, INBRED SHR; VASODILATOR AGENTS;

RATTUS;

EID: 79960673835     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011023     Document Type: Article

References (52)

1. Hermann M, Flammer A, Lü scher T. Nitric oxide in hypertension. J Clin Hypertens 2006;8(Suppl. 4):17-29
2. Muller B, Kleschyov AL, Alencar JL, Vanin A, Stoclet JC. Nitric oxide transport and storage in the cardiovascular system. Ann NY Acad Sci 2002;962:131-9
3. Vanin AF. Dinitrosyl iron complexes and S-nitrosothiols are two possible forms for stabilization and transport of nitric oxide in biological systems. Biochemistry 1998;63:782-93
4. Vanin AF. Dinitrosyl iron complexes with thiolate ligands: physico-chemistry, biochemistry and physiology. Nitric Oxide 2009;2:1-13
5. Manukhina EB, Vanin AF, Markov KM, Malyshev IYu. Formation and role of nitric oxide stores in adaptation to hypoxia. Adv Med Biol 2006;578:35-40
6. Manukhina EB, Vanin AF, Malyshev IYu, Mallet RT, Downey HF. Intermittent hypoxia-induced cardio- and vasoprotection: role of NO stores. In: Xi L, Serebrovskaya TV, eds. Intermittent Hypoxia: From Molecular Mechanisms to Clinical Applications. Hauppauge: Nova Science Publishers, 2009:113-46
7. Mokh VP, Poltorakov AP, Serezhenkov VA, Vanin AF. On the nature of a compound formed from dinitrosyl-iron complexes with cysteine and responsible for a long-lasting vasorelaxation. Nitric Oxide 2010;22:266-74
8. Yang Y, Loscalzo J. S-Nitrosated proteins: formation, metabolism and function. In: van Faassen E, Vanin AF, eds. Radicals for Life: The Various Forms of Nitric Oxide. Amsterdam: Elsevier, 2007:201-21
9. Manukhina EB, Downey HF, Mallet RT. Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia. Exp Biol Med 2006;231:343-65
10. Serebrovskaya TV, Manukhina EB, Smith ML, Downey HF, Mallet RT. Intermittent hypoxia: cause of or therapy for systemic hypertension? Exp Biol Med 2008;233:627-50
11. Vorob'ev LP, Chizhov AIa, Potievskaia VI. The possibilities of using intermittent normobaric hypoxia for treating hypertension patients. Ter Arkh 1994;66:12-5 [Russian]
12. Mukharliamov FIu, Smirnova MI, Bedritskii SA, Liadov KV. Interval hypoxic training in arterial hypertension. Vopr Kurortol Fizioter Lech Fiz Kult 2006;2:5-6 [Russian]
13. Simonenko VB, Ermolaev AL, Potievskaia VI, Stepaniants OS. Hypoxic therapy of arterial hypertension in patients with different variability of arterial pressure. Klin Med (Mosk) 2003;81:35-8 [Russian]
14. Balykin MV, Vinogradov SN, Gening TP. Effect of normobaric hypoxia and physical load on the functional indices of cardiorespiratory system in overweight people. Vopr Kurortol Fizioter Lech Fiz Kult 2004;1:18-21 [Russian]
15. Lyamina NP, Senchikhin VN, Pokidyshev DA, Manukhina EB. Disturbed NO production in patients with essential hypertension and a non-drug method of its correction. Kardiologiia 2001;41:17-21 [Russian]
16. Zong P, Setty S, Sun W, Martinez R, Tune JD, Ehrenburg IV, Tkatchouk EN, Mallet RT, Downey HF. Intermittent hypoxic training protects canine myocardium from infarction. Exp Biol Med 2004;229:806-12
17. Serebrovskaya TV. Intermittent hypoxia research in the former Soviet Union and the Commonwealth of Independent States: history and review of the concept and selected applications. High Alt Med Biol 2002;3:205-21
18. Vanin AF, Sanina NA, Serezhenkov VA, Burbaev DSh, Lozinsky VI, Aldoshin SM. Dinitrosyl-iron complexes with thiol-containing ligands: spatial and electronic structures. Nitric Oxide 2007;16:82-93
19. Vanin AF, Poltorakov AP, Mikoyan VD, Kubrina LN, Burbaev DS. Polynuclear water-soluble dinitrosyl iron complexes with cysteine or glutathione ligands: electron paramagnetic resonance and optical studies. Nitric Oxide 2010;23:136-49
20. Vlasova MA, Smirin BV, Pokidyshev DA, Mashina SY, Vanin AF, Malyshev IY, Manukhina EB. Mechanism of adaptation of the vascular system to chronic changes in nitric oxide level in the organism. Bull Exper Biol Med 2006;142:670-4
21. Vlasova MA, Vanin AF, Muller B, Smirin BV, Malyshev IY, Manukhina EB. Detection and description of various stores of nitric oxide store in vascular wall. Bull Exp Biol Med 2003;136:226-30
22. Smirin BV, Vanin AF, Malyshev IY, Pokidyshev DA, Manukhina EB. Nitric oxide depot in blood vessels in vivo. Biull Eksp Biol Med 1999;127:629-32 [Russian]
23. Manukhina EB, Malyshev IIu, Maleniuk EB, Zenina TA, Pokidyshev DA, Mikoian VD, Kubrina LN, Vanin AF. Hypotensive effect and tissue distribution of the dinitrosyl iron complexes, a nitric oxide donor. Bull Exp Biol Med 1998;1:23-5
24. Foster GE, Poulin MJ, Hanly PJ. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 2007;92:51-65
25. Smith ML. Sleep apnoea and hypertension: physiological bases for a causal relation themed issue. Exp Physiol 2007;92:19-20
26. Kanagy N. Vascular effects of intermittent hypoxia. ILAR J 2009;50:282-8
27. Neubauer JA. Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol 2001;90:1593-9
28. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997;99:106-9
29. Fletcher EC, Lesske J, Qian W, Miller CC 3rd, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 1992;19:555-61
30. Tahawi Z, Orolinova N, Joshua IG, Bader M, Fletcher EC. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 2001;90:2007-13
31. Phillips SA, Olson EB, Morgan BJ, Lombard JH. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 2004;286:H388-H93
32. Cai Y, Deng X, Zhou X, Zheng Y, Wang X, Liang B, Cai Q, Yang Y. The hypoxic moderation of systemic hypertension in spontaneously hypertensive rats. Chin Med Sci J 1993;8:125-8
33. Obrezchikova MN, Kharchenko IB, Tarasova OS, Koshelev VB. Intermittent hypoxic training in an altitude chamber decelerates but not prevents development of genetically determined hypertension in rats. Hypox Med J 1997;5:3-7
34. Manukhina EB, Mashina SIu, Smirin BV, Lyamina NP, Senchikhin VN, Vanin AF, Malyshev IY. Role of nitric oxide in adaptation to hypoxia and adaptive defense. Physiol Res 2000;49:89-97
35. Llorens S, Ferna ́ndez AP, Nava E. Cardiovascular and renal alterations on the nitric oxide pathway in spontaneous hypertension and ageing. Clin Hemorheol Microcirc 2007;37:149-56
36. Nava E, Farre AL, Moreno C, Casado S, Moreau P, Cosentino F, Luscher TF. Alterations to the nitric oxide pathway in the spontaneously hypertensive rat. J Hypertens 1998;16:609-15
37. Racasan S, Branko Braam B, Koomans HA, Joles JA. Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon. Am J Physiol Renal Physiol 2005;288:F626-36
38. Hong H-J, Loh S-H, Yen M-H. Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase. Br J Pharmacol 2000;131:631-7
39. Puddu P, Puddu GM, Zaca F, Muscari A. Endothelial dysfunction in hypertension. Acta Cardiol 2000;55:p221-32
40. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010;459:923-39
41. Wu C-C, Yen M-H. Nitric oxide synthase in spontaneously hypertensive rats. Biomed Sci 1997;4:p249-55
42. Muller B, Kleschyov AL, Stoclet JC. Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl iron complexes in lipopolysaccharide-treated rat aorta. Br J Pharmacol 1996;119:1281-5
43. Mülsch A, Mordvintcev P, Vanin AF, Busse R. The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron(II) complex is stored in a protein-bound form in vascular tissue and is released by thiols. FEBS Lett 1991;294:252-6
44. Andrews KL, McGuire JJ, Triggle CR. A photosensitive vascular smooth muscle store of nitric oxide in mouse aorta: no dependence on expression of endothelial nitric oxide synthase. Br J Pharmacol 2003;138:932-40
45. Chauhan S, Rahman A, Nilsson H, Clapp L, MacAllister R, Ahluwalia A. NO contributes to EDHF-like responses in rat small arteries: a role for NO stores. Cardiovasc Res 2003;57:207-16
46. Manukhina EB, Malyshev IY, Smirin BV, Mashina SY, Saltykova VA, Vanin AF. Production and storage of nitric oxide in adaptation to hypoxia. Nitric Oxide 1999;5:393-401
47. Manukhina EB, Vanin AF, Vlasova MA, Smirin BV, Mashina SY, Malyshev IY, Downey HF. Modulation of NO stores: a new mechanism of vascular adaptation to chronic changes in plasma NO. J Physiol Sci 2009;59:406 (abstract)
48. Downey HF, Manukhina EB, Barlow M, Vanin AF, Mikoyan VD, Caffrey JL. Metabolic syndrome depresses NO storage in canine coronary arteries. J Physiol Sci 2009;59:325 (abstract)
49. Ryou MG, Sun J, Oguayo KN, Manukhina EB, Downey HF, Mallet RT. Hypoxic conditioning suppresses nitric oxide production upon myocardial reperfusion. Exp Biol Med 2008;233:766-74
50. Mallet RT, Ryou M-G, Manukhina EB, Downey HF. Beta-adrenergic signaling and ROS: pivotal roles in intermittent, normobaric hypoxia-induced cardioprotection. In: Xi L, Serebrovskaya TV, eds. Intermittent Hypoxia: From Molecular Mechanisms to Clinical Applications. Hauppauge: Nova Science Publishers, 2009:189-212
51. Mallet RT, Ryou M-G, Manukhina EB, Downey HF. Intermittent hypoxic conditioning of canine myocardium: robust protection against ischemia-reperfusion injury. In: Lukyanova L, Takeda N, Singal PK, eds. Adaptation Biology and Medicine: Health Potentials. Vol. 5. New Delhi: Narosa Publishers, 2008:59-78
52. Manukhina EB, Downey HF, Mallet RT, Goryacheva AV, Malyshev IY, Vanin AF. Role of nitric oxide (NO) stores in adaptive defense against NO overproduction. In: Wang P, Kuo C-H, Takeda N, Singal PK, eds. Adaptation Biology and Medicine, Vol. 6: Cell Adaptations and Challenges. New Delhi: Narosa Publishing House Ltd, 2010:293-315